**Author details**

*Advances in Complex Valvular Disease*

○ Atrial fibrillation

• Interventions in asymptomatic patients

○ Obstructive coronary artery disease

• Prosthetic tissue and structural options

○ Bovine vs porcine vs non-biologic

○ Anti-calcification treatments

○ Stented vs non-stented

○ Stent material

**5. Conclusions**

pathology.

**Conflict of interest**

○ Other valvular pathologies

1.Mitral, tricuspid

• Evolving repair technologies

○ Aortic aneurysms

• Impact of and options for concomitant cardiac pathologies

The list of topics that can be reviewed is endless, clearly beyond the scope of a single text, and only serves to illustrates the importance of having a solid foundation in the existing literature, guidelines, and technologies as we move forward with regards to how we objectively assess and manage patient with aortic valve pathology. While patient preferences clearly should have a role, it is imperative that patients and their families be provided with accurate and objective data that take their personal characteristics into consideration so that their decisions can be properly guided with the goal of optimizing their opportunities for an ideal short- and long-term outcome. Hopefully, texts such as this along with multidisciplinary Heart Teams can help improve these short- and long-term outcomes in terms of quality and quantity of life for those patients with significant valvular

Dr Firstenberg serves as a heart valve repair and replacement educational consultant for Medtronic plc. Dr Hanna reports no conflicts of interest or relevant

disclosures in the context of the material presented in this chapter.

**10**

Michael S. Firstenberg1 \* and Jennifer Hanna<sup>2</sup>

1 Research and Special Projects: William Novick Global Cardiac Alliance, Memphis, TN, US

2 Department of Cardiothoracic and Vascular Surgery, The Medical Center of Aurora, Aurora, CO, US

\*Address all correspondence to: msfirst@gmail.com; michael.firstenberg@cardiac-alliance.org

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
